medline.ch Gastroenterologie Leber Neoplasie

	The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma. Front Immunol Lin H, Wang X, Zhong J, Peng N, Liu S, Zeng F, Li W, Su Z, Ou J, Wu P, Yao H, Li S. PMID: 42112317 [PubMed - indexed for MEDLINE]
	Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study. Front Public Health Yang XJ, Yang XQ, Mo XY, Zuo J, Fan YC. PMID: 42110297 [PubMed - indexed for MEDLINE]
	NF-ÎºB Signaling Pathway Activation in Aflatoxin B1-Induced Hepatocellular Toxicity: Molecular Crosstalk With Oxidative Stress and IÎºB Degradation. J Biochem Mol Toxicol Hosawi S. PMID: 42108774 [PubMed - indexed for MEDLINE]
	Infection-Associated Microecology and Hepatocellular Carcinoma. Methods Mol Biol Song Q. PMID: 42108298 [PubMed - indexed for MEDLINE]
	A Case of Pernicious Anemia Induced by Atezolizumab in Hepatocellular Carcinoma and Renal Cell Carcinoma. Am J Case Rep Sugimoto T, Kanemori G, Kanehira H, Kitao A, Nagatani Y. PMID: 42106905 [PubMed - indexed for MEDLINE]
	Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy. Sci Rep Elkramani N, Elzallat M, Mohammed DM, AbdelLatif A, Aboushousha T, El-Ahwany E. PMID: 42106389 [PubMed - indexed for MEDLINE]
	Microwave Ablation with or without TACE for Unresectable Large Hepatocellular Carcinoma: Impact of Tumor Burden Score on Efficacy. J Gastrointest Cancer Wang Z, Wang Z, Li J, Li L, Wang S, Liu F, Yu J, Liang P, Yu X. PMID: 42105132 [PubMed - indexed for MEDLINE]
	Development of a machine learning-based prognostic prediction model and a web-based tool for pediatric hepatoblastoma: a Surveillance, Epidemiology, and End Results (SEER) database study. Pediatr Surg Int Chen Z, Wei Y, Liu S, Zhang J. PMID: 42105007 [PubMed - indexed for MEDLINE]
	TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study. Front Immunol Su Y, Liang Y, Zhong D, Chen Y, Wang M, Yang Q, Yan H, Huang X. PMID: 42099657 [PubMed - indexed for MEDLINE]
	Current progress and emerging trends of car-based immunotherapy for hepatocellular carcinoma: a data-driven atlas from multidatabase integration. Front Immunol Ying H, Pan Y, Zhu X, Xuan Q. PMID: 42099608 [PubMed - indexed for MEDLINE]
	Inflammation in hepatocellular carcinoma progression: a "Single Wick, dual interwoven strands" regulatory framework. Front Immunol Wu C, Dong J, Sui S, Tan X, Zhu N. PMID: 42099598 [PubMed - indexed for MEDLINE]
	Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstruction. Cancer Imaging Moos M, Emrich T, Nguyen M, Steinmetz S, Kloeckner R, Hahn F, Steiner P, Scholz C, Moehler M, Lang H, Bäuerle T, Jorg T, Müller L. PMID: 42098885 [PubMed - indexed for MEDLINE]
	Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. PLoS One Nishioka C, Tahata Y, Maesaka K, Kai M, Shirai K, Murai K, Makino Y, Saito Y, Nozaki Y, Nakabori T, Ishida H, Yakushijin T, Iio S, Tatsumi N, Imanaka K, Kakita N, Sakamori R, Hosui A, Miyazaki M, Matsumoto K, Nakahara M, Doi Y, Sakakibara M, Hikita H, Kodama T, Takehara T. PMID: 42096473 [PubMed - indexed for MEDLINE]
	Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinoma. Theranostics Yilmaz EY, Schmidt R, Heidemann L, He Y, Liu Y, Sulejmani O, Müller DN, Wilhelm A, Auer TA, Hamm CA, Abosabie SAS, Abosabie SA, Gebauer B, Savic LJ. PMID: 42094598 [PubMed - indexed for MEDLINE]
	Fenugreek seed extract-doxorubicin synergy against hepatocellular carcinoma in HepG2 cells: in vitro and in silico mechanistic studies. BMC Complement Med Ther Ragab W, Mahmoud K, Allam RM, Qayed WS, Gomaa OM, El-Hawary SS, Moawad AS, Mohammed R. PMID: 42092913 [PubMed - indexed for MEDLINE]
	Sintilimab (PD-1 inhibitor) plus lenvatinib as conversion therapy followed by sequential surgery (SILENSES) for advanced unresectable hepatocellular carcinoma: a phase II, expansion trial. Signal Transduct Target Ther Lu S, Zhang W, Li J, Zhang Z, Hu B, Li X, Cao Y, Wang Z, Wang Z, Ye H, Qu B, Li Y, Ma G, Wan T, Liu Z, Liu B, Xu Y, Tang H, Zhao X, Pan L, Yang L, Yuan J, Chen R, Bian X. PMID: 42091859 [PubMed - indexed for MEDLINE]
	Nutritional Risk Assessed by Royal Free Hospital-Nutritional Prioritizing Tool Predicts Survival in Cirrhosis With or Without Hepatocellular Carcinoma. J Korean Med Sci Park HJ, Jung JK, Noh J, Kim Y, Lee SU, Yun BC, Lee JW, Kim HJ, Seo KI. PMID: 42089136 [PubMed - indexed for MEDLINE]
	Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era. BMJ Open Gastroenterol Chen S, Shen L, Qi H, Hu P, Cao F, Xie L, Wang Y, Fan W. PMID: 42086291 [PubMed - indexed for MEDLINE]
	Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma. Radiology Berman ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, Sandow T, Gimenez J, Young S, Fidelman N, Pianka KT, Sher A, Alamuri T, Chan SM, Vakil P, Wang M, Abounorinejad F, Som A, Johnson GE, Padia SA, Kim E, Toskich BB. PMID: 42084516 [PubMed - indexed for MEDLINE]
	Diffusion-weighted Imaging of the Liver: Primed for New Business. Radiology Brunsing RL, Syed AB, Hargreaves BA, Ennis DB. PMID: 42084512 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 76057

Seite 1 von 3803

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung